BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14512910)

  • 1. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
    Nijsten TE; Stern RS
    J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
    Harwood CA; Leedham-Green M; Leigh IM; Proby CM
    Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis, its treatment, and cancer in a cohort of Finnish patients.
    Hannuksela-Svahn A; Pukkala E; Läärä E; Poikolainen K; Karvonen J
    J Invest Dermatol; 2000 Mar; 114(3):587-90. PubMed ID: 10692122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL; Stern RS
    J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
    Sarnoff DS; Saini R
    J Drugs Dermatol; 2008 May; 7(5):475-8. PubMed ID: 18505142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE; Stern RS
    J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the chemoprevention of non-melanoma skin cancer in high-risk organ transplant recipients.
    Lien MH; Fenske NA; Glass LF
    Semin Oncol; 2012 Apr; 39(2):134-8. PubMed ID: 22484184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.